PMID: 42443448

Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.

Yang Qinghuan, Zhang Yiyao, Liu Pingping, Yan Zhiwen, Li Changqing, Tang Yinghong, Yang Qin

Neurochemical research · 2026

Vol. 51, Issue 4

View on PubMedDOI

This entry links to third-party literature. For research use only.

AnimalsReceptors, ImmunologicMaleMembrane GlycoproteinsMiceNeuroprotective AgentsMice, Inbred C57BLDrug Therapy, CombinationApoptosisBrain Ischemia

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.